drugset / Trial / NCT07550231
Determining the Optimal Dose of AD-211 in Patients With Osteoarthritis of the Knee
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine the optimal dose of AD-211 in patients with osteoarthritis of the knee.
Timeline
- Start
- 2026-06
- Primary completion
- 2027-03
- Completion
- 2027-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AD-211 | Unknown | — | Oral |
| Comparator | AD-2113 | Unknown | — | Oral |